Vera Therapeutics, Inc. (VERA): Price and Financial Metrics


Vera Therapeutics, Inc. (VERA): $15.89

1.05 (+7.08%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VERA to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

VERA Stock Price Chart Interactive Chart >

Price chart for VERA

VERA Price/Volume Stats

Current price $15.89 52-week high $37.11
Prev. close $14.84 52-week low $13.01
Day low $15.05 Volume 60,500
Day high $16.24 Avg. volume 99,425
50-day MA $20.02 Dividend yield N/A
200-day MA $20.94 Market Cap 424.95M

Vera Therapeutics, Inc. (VERA) Company Bio


Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.


VERA Latest News Stream


Event/Time News Detail
Loading, please wait...

VERA Latest Social Stream


Loading social stream, please wait...

View Full VERA Social Stream

Latest VERA News From Around the Web

Below are the latest news stories about Vera Therapeutics Inc that investors may wish to consider to help them evaluate VERA as an investment opportunity.

We Think Vera Therapeutics (NASDAQ:VERA) Can Afford To Drive Business Growth

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Yahoo | February 22, 2022

Vera Therapeutics Announces Closing of Upsized Public Offering of Class A Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

BRISBANE, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera”), a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the closing of its public offering of 5,742,026 shares of its Class A common stock at a price to the public of $15.00 per share, which includes the full exercise of the underwriters’ option to purchase up to 748,959 additional shares. The gross

Yahoo | February 14, 2022

Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common Stock

BRISBANE, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera”) (Nasdaq: VERA), a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the pricing of its public offering of 4,993,067 shares of its Class A common stock at a price to the public of $15.00 per share. The gross proceeds to Vera from the offering, before deducting the underwriting discounts and commiss

Yahoo | February 10, 2022

Vera Therapeutics announces public offering of 4M class A shares

Vera Therapeutics (NASDAQ:VERA) commenced a public offering to issue and sell 4M class A shares. VERA expects to grant the underwriters a 30-day option to purchase up to an additional 600K class A shares....

Seeking Alpha | February 7, 2022

Vera Therapeutics Announces Commencement of Public Offering of Class A Common Stock

BRISBANE, Calif., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera”), a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that it has commenced a public offering, subject to market and other conditions, to issue and sell 4,000,000 shares of its Class A common stock. All of the shares are being offered by Vera. In connection with the proposed offering, Vera expects

Yahoo | February 7, 2022

Read More 'VERA' Stories Here

VERA Price Returns

1-mo -20.55%
3-mo -31.54%
6-mo -55.61%
1-year -7.88%
3-year N/A
5-year N/A
YTD -40.53%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6217 seconds.